Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications (original) (raw)
Related papers
NANOTECHNOLOGY: AN EMERGING TOOL FOR EFFECTIVE CANCER TREATMENT
ARTICLE INFO ABSTRACT Nanotechnology is rapidly progressing and is being implemented to solve the problems related to conventional chemotherapeutic agents such as low safety margin, poor water solubility, poor oral availability, normal tissue toxicity and tumor resistance. Nanotechnology promises targeted delivery of drugs and significant improvement in cancer diagnosis, treatment and management. Nanoparticle assisted combination therapies promotes synergism, enhances therapeutic effectiveness, improves pharmacokinetics and suppresses drug resistance. This review sheds light on various nanotechnological platforms as anticancer drug delivery vehicles, raises awareness of the advantages of therapeutic applications of anticancer agents using nanoparticles, minimizing the normal tissue toxicity, drug resistance and treatment of disseminated metastatic cells through targeted therapy.
Novel Methods in Nanomedicine for Drug Delivery Systems: Cancer Therapies
Biomedical Journal of Scientific & Technical Research, 2017
Nanotechnology is a general design science that will provide us strong novel implements that may modification every attribute of community. These technologies will location in our hands the potency to design problem at the atomic and molecular level. We will be capable to finally construct available products on-demand and more cheaply. More interestingly, using inherent ideologies and developments, we will design produces that have never existed in nature. The main challenges in the efficient treatment of cancer patients are low effectiveness in drug delivery and inherent drug resistance in extremely heterogeneous human tumors. Chemotherapy drugs have little blood half-lives and confined extents of drugs can be delivered into tumors despite a lot doses of drugs being controlled to patients that reason severe systemic toxicity. Significant attentions when considering the potential that nanotechnology maintain to treat cancer.
Nanotechnology in cancer therapy
Journal of Drug Targeting, 2013
Cancer is one of the major causes of mortality worldwide and advanced techniques for therapy are urgently needed. The development of novel nanomaterials and nanocarriers has allowed a major drive to improve drug delivery in cancer. The major aim of most nanocarrier applications has been to protect the drug from rapid degradation after systemic delivery and allowing it to reach tumor site at therapeutic concentrations, meanwhile avoiding drug delivery to normal sites as much as possible to reduce adverse effects. These nanocarriers are formulated to deliver drugs either by passive targeting, taking advantage of leaky tumor vasculature or by active targeting using ligands that increase tumoral uptake potentially resulting in enhanced antitumor efficacy, thus achieving a net improvement in therapeutic index. The rational design of nanoparticles plays a critical role since structural and physical characteristics, such as size, charge, shape, and surface characteristics determine the biodistribution, pharmacokinetics, internalization and safety of the drugs. In this review, we focus on several novel and improved strategies in nanocarrier design for cancer therapy.
Advances of Cancer Therapy by Nanotechnology
Cancer Research and Treatment, 2009
Recent developments in nanotechnology offer researchers opportunities to significantly transform cancer therapeutics. This technology has enabled the manipulation of the biological and physicochemical properties of nanomaterials to facilitate more efficient drug targeting and delivery. Clinical investigations suggest that therapeutic nanoparticles can enhance efficacy and reduced side effects compared with conventional cancer therapeutic drugs. Encouraged by rapid and promising progress in cancer nanotechnology, researchers continue to develop novel and efficacious nanoparticles for drug delivery. The use of therapeutic nanoparticles as unique drug delivery systems will be a significant addition to current cancer therapeutics.
Nanotechnology for cancer treatment
Nanotechnology Reviews, 2014
Nanotechnology has the potential to increase the selectivity and potency of chemical, physical, and biological approaches for eliciting cancer cell death while minimizing collateral toxicity to nonmalignant cells. Materials on the nanoscale are increasingly being targeted to cancer cells with great specificity through both active and passive targeting. In this review, we summarize recent literature that has broken new ground in the use of nanotechnology for cancer treatment with an emphasis on targeted drug delivery.
Nanotechnology has achieved the status as one of the vital research endeavors of 21st century, which may be called as “Nano-Century” with nanotechnology making its presence felt in different spheres of lives. Nanotechnology may be defined as the creation of materials, drugs and devices that are used to manipulate matter of size in the range of 1-100nm. Nanotechnology has found its applications in many fields related to medicine including novel drug delivery systems. Many different types of nanosystems have been utilized in diagnostics and therapeutics of various diseases. To subside the disadvantages of conventional cancer therapeutics, nanotechnology has been given considerable attention. The purpose of this expert review is to discuss the impact of nanotechnology in the treatment of the cancer. These have been applied to improve drug delivery and to overcome some of the problems of drug delivery in cancer. Current nanotechnology platforms for cancer therapeutics encompass a vast a...
Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment
Anticancer research, 2017
The emerging field of nanotechnology meets the demands for innovative approaches in the diagnosis and treatment of cancer. The nanoparticles are biocompatible and biodegradable and are made of a core, a particle that acts as a carrier, and one or more functional groups on the core which target specific sites. Nanotech in drug delivery includes nanodisks, High Density Lipoprotein nanostructures, liposomes, and gold nanoparticles. The fundamental advantages of nanoparticles are: improved delivery of water-insoluble drugs, targeted delivery, co-delivery of two or more drugs for combination therapy, and visualization of the drug delivery site by combining imaging system and a therapeutic drug. One of the potential applications of nanotechnology is in the treatment of cancer. Conventional methods for cancer treatments have included chemotherapy, surgery, or radiation. Early recognition and treatment of cancer with these approaches is still challenging. Innovative technologies are needed ...
Nanotechnology of Cancer Therapy: An Overview
Current Research in Pharmaceutical Sciences, 2017
Nanotechnology is the study and use of structures between 1 nanometer and 100 nanometers in size. Nanotechnology is definitely a medical boon for diagnosis, treatment and prevention of cancer diseases. Nanoparticulate technology is of particular use in developing a new generation of more effective cancer therapies capable of overcoming many biological, biophysical and biomedical barriers that the body stages against a standard intervention. Nanoparticles that deliver chemotherapy drugs directly to cancer cells are under development. Nanomedicine application areas include drugdelivery, therapy, diagonistic, imaging and antimicrobial techniques. The formed nano particles can be used in wide range of therapeutic treatment of cancer. To overcome problems of systemic toxicity associated with chemotherapy and enhance treatment resolution of cancer therapies, nanotechnology is increasingly providing many novel approaches, especially to energy-based cancer therapies. Nonmaterial and biomarkers of cancer, general principle of drug targeting to cancer, intracellular mechanisms, and nanoparticles based formulation in market, several recent applications in medicine as diagnostic and therapeutic are discussed. This article aim to overview on all the parts of nanotechnology in cancer therapy.
Conventional Nanosized Drug Delivery Systems for Cancer Applications
Advances in Experimental Medicine and Biology
Clinical responses and tolerability of conventional nanocarriers (NCs) are sometimes different from those expected in anticancer therapy. Thus, new smart drug delivery systems (DDSs) with stimuli-responsive properties and novel materials have been developed. Several clinical trials demonstrated that these DDSs have better clinical therapeutic efficacy in the treatment of many cancers than free drugs. Composition of DDSs and their surface properties increase the specific targeting of therapeutics versus cancer cells, without affecting healthy tissues, and thus limiting their toxicity versus unspecific tissues. Herein, an extensive revision of literature on NCs used as DDSs for cancer applications has been performed using the available bibliographic databases.
Nanomedicine: an effective tool in cancer therapy
International journal of pharmaceutics, 2018
Various types of nanoparticles (NPs) have been used in delivering anticancer drugs to the site of action. This area has become more attractive in recent years due to optimal size and negligible undesirable side effects caused by the NPs. The focus of this review is to explore various types of NPs and their surface/chemical modifications as well as attachment of targeting ligands for tuning their properties in order to facilitate targeted delivery to the cancer sites in a rate-controlled manner. Heme compatibility, biodistribution, longer circulation time, hydrophilic lipophilic balance for high bioavailability, prevention of drug degradation and leakage are important in transporting drugs to the targeted cancer sites. The review discusses advantages of polymeric, magnetic, gold, and mesoporous silica NPs in delivering chemotherapeutic agents over the conventional dosage formulations along with their shortcomings/risks and possible solutions/alternatives.